Search research articles
Contact Us
Filters
Showing results (31-40 of 118) with videos related to
Page
of 12
Sort By:
Prostate Cancer and Prostatic Diseases
|
June 3, 2018
Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer
Karthik V Giridhar, Cristobal Sanhueza, David W Hillman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
June 26, 2026
Pancreatic resection for metastatic renal cell carcinoma: outcomes in the era of immunotherapy and targeted therapy
Hala Muaddi, Leo Li-Han, Brian A Costello, et al.
Urology
|
September 10, 2011
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma
Simon P Kim, Christopher J Weight, Bradley C Leibovich, et al.
Cancer
|
September 7, 2012
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma
Simon P Kim, Paul L Crispen, R Houston Thompson, et al.
The Journal of Urology
|
October 30, 2019
Reply by Authors
Timothy D Lyon, R Houston Thompson, Paras H Shah, et al.
The Journal of Urology
|
August 9, 2019
Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era
Timothy D Lyon, R Houston Thompson, Paras H Shah, et al.
JAMA Network Open
|
October 21, 2025
Testicular Cancer-Associated Paraneoplastic Neurologic Syndromes
Ehab Harahsheh, M Bakri Hammami, Pranjal Gupta, et al.
Urology
|
July 26, 2016
Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma
Sarah P Psutka, John C Cheville, Brian A Costello, et al.
Pathology
|
August 27, 2015
High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma
Sounak Gupta, R Houston Thompson, Stephen A Boorjian, et al.
BMC Urology
|
June 24, 2022
Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer
Ahmed M Mahmoud, Igor Frank, Jacob J Orme, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 118) with videos related to
Sort By:
Page
of 12
Prostate Cancer and Prostatic Diseases
|
June 3, 2018
Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer
Karthik V Giridhar, Cristobal Sanhueza, David W Hillman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
June 26, 2026
Pancreatic resection for metastatic renal cell carcinoma: outcomes in the era of immunotherapy and targeted therapy
Hala Muaddi, Leo Li-Han, Brian A Costello, et al.
Urology
|
September 10, 2011
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma
Simon P Kim, Christopher J Weight, Bradley C Leibovich, et al.
Cancer
|
September 7, 2012
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma
Simon P Kim, Paul L Crispen, R Houston Thompson, et al.
The Journal of Urology
|
October 30, 2019
Reply by Authors
Timothy D Lyon, R Houston Thompson, Paras H Shah, et al.
The Journal of Urology
|
August 9, 2019
Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era
Timothy D Lyon, R Houston Thompson, Paras H Shah, et al.
JAMA Network Open
|
October 21, 2025
Testicular Cancer-Associated Paraneoplastic Neurologic Syndromes
Ehab Harahsheh, M Bakri Hammami, Pranjal Gupta, et al.
Urology
|
July 26, 2016
Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma
Sarah P Psutka, John C Cheville, Brian A Costello, et al.
Pathology
|
August 27, 2015
High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma
Sounak Gupta, R Houston Thompson, Stephen A Boorjian, et al.
BMC Urology
|
June 24, 2022
Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer
Ahmed M Mahmoud, Igor Frank, Jacob J Orme, et al.
Page
of 12